Terms: = Lymphoma AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
973 results:
1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
2. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
[TBL] [Abstract] [Full Text] [Related]
4. Metabolic tumour volume in Hodgkin lymphoma-A comparison between manual and AI-based analysis.
Sadik M; Barrington SF; Trägårdh E; Saboury B; Nielsen AL; Jakobsen AL; Gongora JLL; Urdaneta JL; Kumar R; Edenbrandt L
Clin Physiol Funct Imaging; 2024 May; 44(3):220-227. PubMed ID: 38011940
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
6. Chemokine Receptor PET/CT Provides Relevant staging and Management Changes in Marginal Zone lymphoma.
Duell J; Buck AK; Hartrampf PE; Schlötelburg W; Schneid S; Weich A; Dreher N; Lapa C; Kircher M; Higuchi T; Samnick S; Serfling SE; Raderer M; Rasche L; Einsele H; Topp MS; Kosmala A; Werner RA
J Nucl Med; 2023 Dec; 64(12):1889-1894. PubMed ID: 37797975
[TBL] [Abstract] [Full Text] [Related]
7. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
[No Abstract] [Full Text] [Related]
8. [Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma].
Shan DD; Liu HM; Liu W; Huang WY; Lyu R; Deng SH; Yi SH; An G; Xu Y; Sui WW; Wang TY; Fu MW; Zhao YZ; Qiu LG; Zou DH
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):555-560. PubMed ID: 37749034
[No Abstract] [Full Text] [Related]
9. [Efficacy and safety of bendamustine-rituximab combination therapy for newly diagnosed indolent B-cell non-Hodgkin's lymphoma and elderly mantle cell lymphoma: a multi-center prospective phase II clinical trial in China].
Wang H; He Q; Liu D; Deng XZ; Ma J; Xie LN; Sun ZL; Liu C; Zhao RR; Lu K; Chu XX; Gao N; Wei HC; Sun YH; Zhong YP; Xing LJ; Zhang HY; Zhang H; Xu WW; Li ZJ
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):550-554. PubMed ID: 37749033
[No Abstract] [Full Text] [Related]
10. Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.
Ferdinandus J; van Heek L; Roth K; Dietlein M; Eich HT; Baues C; Borchmann P; Kobe C
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):490-495. PubMed ID: 37735258
[TBL] [Abstract] [Full Text] [Related]
11. [
Peng L; Liao Y; Zhou R; Zhong Y; Jiang H; Wang J; Fu Y; Xue L; Zhang X; Sun M; Feng G; Meng Z; Peng S; He X; Teng G; Gao X; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3723-3734. PubMed ID: 37401938
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.
Kutluk T; Sahin B; Kirazli M; Ahmed F; Aydin S; Yesil Çinkir H; Sezgin G; Bayram I; Ebinç S; Isikdogan A; Sasmaz I; Okan V; Ilhan G; Ören AC; Akbayram S; Harputluoglu H; Ural C; Ayyildiz O; Aktas G; Uçar MA; Güvenç B; Köse D; Acipayam C; Güncan S; Erçolak V; Berber I; Akdeniz A; Akyay A; Üzel VH; Söker M; Sengelen M; Yalçin S; Sullivan R
JAMA Netw Open; 2023 May; 6(5):e2312903. PubMed ID: 37219908
[TBL] [Abstract] [Full Text] [Related]
13. Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis.
Zheng Y; Liu J; Si J; Xue Q; Chen D; Nuermaimaiti R; Tian C
Ann Hematol; 2023 Sep; 102(9):2403-2412. PubMed ID: 37209118
[TBL] [Abstract] [Full Text] [Related]
14. Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
Maccioni F; Alfieri G; Assanto GM; Mattone M; Gentiloni Silveri G; Viola F; De Maio A; Frantellizzi V; Di Rocco A; De Vincentis G; Pulsoni A; Martelli M; Catalano C
Radiol Med; 2023 May; 128(5):556-564. PubMed ID: 37145214
[TBL] [Abstract] [Full Text] [Related]
15. Enhancing information on stage at diagnosis of cancer in Africa.
Parkin DM; Liu B; Adoubi I; Makouanzi AS; Masalu N; Mrema C; Ndlovu N; Omonisi A; Traore B; Joko-Fru Y
Acta Oncol; 2023 Apr; 62(4):335-341. PubMed ID: 37102435
[TBL] [Abstract] [Full Text] [Related]
16. Nomograms for predicting overall survival and cancer-specific survival in patients with head and neck non-Hodgkin lymphoma: A population-based study.
Peng J; Chen J; Liu Y; Lyu J; Zhang B
Medicine (Baltimore); 2023 Feb; 102(6):e32865. PubMed ID: 36820559
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma.
Arslantaş E; Ayçiçek A; Akıcı F; Özkara S; Yılmaz B; Özdemir N; Bayram C
Nuklearmedizin; 2023 Feb; 62(1):20-26. PubMed ID: 36746148
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases].
Su Q; Peng X; Zhou CX; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):13-21. PubMed ID: 36718684
[TBL] [Abstract] [Full Text] [Related]
19. Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.
Li A; La J; May SB; Guffey D; da Costa WL; Amos CI; Bandyo R; Milner EM; Kurian KM; Chen DCR; Do NV; Granada C; Riaz N; Brophy MT; Chitalia V; Gaziano JM; Garcia DA; Carrier M; Flowers CR; Zakai NA; Fillmore NR
J Clin Oncol; 2023 Jun; 41(16):2926-2938. PubMed ID: 36626707
[TBL] [Abstract] [Full Text] [Related]
20. Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.
Quaglino P; Scarisbrick J; Roccuzzo G; Abeldano A; Battistella M; McCormack C; Cowan R; Cozzio A; Cury-Martins J; Enz P; Geskin L; Guenova E; Kim YH; Knobler R; Litvinov IV; Miyagaki T; Molgo M; Nicolay J; Papadavid E; Pinter-Brown L; Pujol Vallverdu R; Querfeld C; Ortiz-Romero P; Stadler R; Vermeer MH; Bagot M; Hodak E
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):680-688. PubMed ID: 36606565
[TBL] [Abstract] [Full Text] [Related]
[Next]
